ProfileGDS5822 / ILMN_1246024
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 93% 97% 96% 91% 97% 93% 97% 96% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1803.493
GSM1276600PDAC Late Ablation Control 21947.497
GSM1276601PDAC Late Ablation Control 31728.196
GSM1276602PDAC Late Ablation 1582.391
GSM1276603PDAC Late Ablation 22195.897
GSM1276604PDAC Late Ablation 3845.193
GSM1303940PDAC Late Ablation_anti-CTLA4 12209.697
GSM1303941PDAC Late Ablation_anti-CTLA4 21724.996
GSM1303942PDAC Late Ablation_anti-CTLA4 31790.996